I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Wainberg, Zev A
225
results:
Search for persons
X
Format
Online (225)
Mediatypes
Articles (Online) (97)
OpenAccess-fulltext (128)
Sorted by: Relevance
Sorted by: Year
?
1
Results of a Randomized, Double-Blind, Placebo-Controlled, ..:
Gardner, Faithlore P.
;
Wainberg, Zev A.
;
Fountzilas, Christos
...
Cancers. 16 (2024) 7 - p. 1323 , 2024
Link:
https://doi.org/10.3390/..
?
2
Pharmacokinetics (PK) of Tiragolumab in First‐in‐Human Stud..:
Garralda, Elena
;
Oh, Do Youn
;
Italiano, Antoine
...
The Journal of Clinical Pharmacology. 64 (2024) 5 - p. 544-554 , 2024
Link:
https://doi.org/10.1002/..
?
3
FGFR-targeted therapeutics: clinical activity, mechanisms o..:
Katoh, Masuko
;
Loriot, Yohann
;
Brandi, Giovanni
...
Nature Reviews Clinical Oncology. 21 (2024) 4 - p. 312-329 , 2024
Link:
https://doi.org/10.1038/..
?
4
Mo1250 PATHOLOGICAL COMPLETE RESPONSE (PCR) TO DURVALUMAB P..:
Molena, Daniela
;
Janjigian, Yelena
;
Al-Batran, Salah-Eddin
...
Gastroenterology. 166 (2024) 5 - p. S-996 , 2024
Link:
https://doi.org/10.1016/..
?
5
Monoclonal antibodies that target fibroblast growth factor ..:
Katoh, Masuko
;
Nakayama, Izuma
;
Wainberg, Zev A
..
Clinical and Translational Medicine. 14 (2024) 6 - p. , 2024
Link:
https://doi.org/10.1002/..
?
6
Bemarituzumab as first-line treatment for locally advanced ..:
Wainberg, Zev A.
;
Kang, Yoon-Koo
;
Lee, Keun-Wook
...
Gastric Cancer. 27 (2024) 3 - p. 558-570 , 2024
Link:
https://doi.org/10.1007/..
?
7
Liposomal irinotecan, oxaliplatin, and S-1 as first-line th..:
Jeong, Hyehyun
;
Kim, Bum Jun
;
Lee, Choong-kun
...
European Journal of Cancer. 208 (2024) - p. 114194 , 2024
Link:
https://doi.org/10.1016/..
?
8
Lymph-node-targeted, mKRAS-specific amphiphile vaccine in p..:
Pant, Shubham
;
Wainberg, Zev A.
;
Weekes, Colin D.
...
Nature Medicine. 30 (2024) 2 - p. 531-542 , 2024
Link:
https://doi.org/10.1038/..
?
9
Ramucirumab plus FOLFIRI or irinotecan as second-line treat..:
Park, Haeseong
;
Klempner, Samuel J.
;
Chao, Joseph
...
Frontiers in Oncology. 14 (2024) - p. , 2024
Link:
https://doi.org/10.3389/..
?
10
Clinical and pathological factors associated with survival ..:
Shimizu, Takayuki
;
Maeda, Shimpei
;
Link, Jason
...
Surgery. 175 (2024) 5 - p. 1377-1385 , 2024
Link:
https://doi.org/10.1016/..
?
11
Pembrolizumab plus chemotherapy versus placebo plus chemoth..:
Rha, Sun Young
;
Oh, Do-Youn
;
Yañez, Patricio
...
The Lancet Oncology. 24 (2023) 11 - p. 1181-1195 , 2023
Link:
https://doi.org/10.1016/..
?
12
Association between gene expression signatures and clinical..:
Shitara, Kohei
;
Di Bartolomeo, Maria
;
Mandala, Mario
...
Journal for ImmunoTherapy of Cancer. 11 (2023) 6 - p. e006920 , 2023
Link:
https://doi.org/10.1136/..
?
13
Dabrafenib plus trametinib in BRAFV600E-mutated rare cancer..:
Subbiah, Vivek
;
Kreitman, Robert J.
;
Wainberg, Zev A.
...
Nature Medicine. 29 (2023) 5 - p. 1103-1112 , 2023
Link:
https://doi.org/10.1038/..
?
14
Second-line treatment options for patients with metastatic ..:
Dayyani, Farshid
;
Macarulla, Teresa
;
Johnson, Andrew
.
Cancer Treatment Reviews. 113 (2023) - p. 102502 , 2023
Link:
https://doi.org/10.1016/..
?
15
Final results of DESTINY-CRC01 investigating trastuzumab de..:
Yoshino, Takayuki
;
Di Bartolomeo, Maria
;
Raghav, Kanwal
...
Nature Communications. 14 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1038/..
1-15